Latest Diabetes News
Isocaloric diets high in animal or plant protein allow similar improvements of metabolism and cardiovascular risk factors in T2DM patients.
These cardiovascular profiles during enteral nutrient exposure may have implications for postprandial hypotension.
The study found that many patients who had a hypoglycemic episode also had high increased odds of cardiovascular disease or death.
The 2017 Updates focus on pharmacologic approaches to glycemic treatment of type 2 diabetes.
Timing of intensification of OAD therapy led to greater reductions in HbA1c and lower risks of complications.
In short-term treatment duration, there was no increased risk of myocardial infarction stroke or heart failure using DPP-4i vs SU/TZD.
Patients who used the drug had a 38% lower risk of dying from kidney cancer than non-users, meta-analysis shows.
Patients with diabetes had higher cumulative rates of 1-year all-cause death, CVD death, and HF hospitalization.
Patients who underwent surgical procedures had a greater mean percentage reduction from baseline in glycated hemoglobin level than did patients who received medical therapy alone.
The largest difference between adolescents with type 2 diabetes vs type 1 diabetes was obesity.
Among the etiologies of readmission, cardiac causes including heart failure and coronary artery disease were most common.
Statistically significant increases in BP, MAP, and serum lipid levels were observed with LY2409021 treatment at a dose that lowered HbA1c and glucose levels.
Participants with high TG and low HDL levels had a 1.32-fold greater HR for CHD than those with normal TG and normal HDL levels.
Swedish smokeless tobacco (snus) increases insulin resistance and the risk of type 2 diabetes.
Dapagliflozin was associated with lower risk of both all-cause mortality and CVD, whereas DPP-4i was only associated with lower risk of all-cause mortality.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)